- With the help of giant Medtronic, Mazor is enjoying considerable commercial success for its two medical robot systems.
- The business model is particularly attractive, generating a large amount of recurring revenues from an increasing installed base.
- There are still multiple growth opportunities ahead.
- Our only worry is competition isn’t sitting still, but we still think the shares have a good risk/reward profile.
Source: Mazor Is Growing Nicely – Mazor Robotics Ltd. (NASDAQ:MZOR) | Seeking Alpha